Utilization pattern and survival outcomes of adjuvant therapies in high‐grade nonretroperitoneal abdominal soft tissue sarcoma: A population‐based study

Nonretroperitoneal abdominal soft tissue sarcoma (NRA‐STS) is a rare disease with limited data supporting its management. Our study aimed to reveal the utilization patterns of adjuvant therapy and its potential survival benefits using the National Cancer Data Base.

[1]  B. Brigman,et al.  The Use of Radiation Therapy in Localized High-Grade Soft Tissue Sarcoma and Potential Impact on Survival , 2015, Annals of Surgical Oncology.

[2]  P. Wong,et al.  Soft Tissue Sarcoma and Radiation Therapy Advances, Impact on Toxicity , 2015, Current Treatment Options in Oncology.

[3]  S. D'Angelo,et al.  Soft tissue tumors of the trunk: Management of local disease in the breast and chest and abdominal walls , 2015, Journal of surgical oncology.

[4]  T. Delaney,et al.  Role of radiation therapy for non‐extremity soft tissue sarcomas , 2015, Journal of surgical oncology.

[5]  T. Curiel,et al.  Immunotherapy for Ovarian Cancer , 2015, Current Treatment Options in Oncology.

[6]  A. Hayes,et al.  A guide to oncological management of soft tissue tumours of the abdominal wall , 2014, Hernia.

[7]  J. Blay,et al.  Genetic Profiling Identifies Two Classes of Soft-Tissue Leiomyosarcomas with Distinct Clinical Characteristics , 2013, Clinical Cancer Research.

[8]  J. Verweij,et al.  Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. , 2012, The Lancet. Oncology.

[9]  R. Slopsema,et al.  Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas. , 2012, International journal of radiation oncology, biology, physics.

[10]  Andrew H. Beck,et al.  ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour , 2012, The Journal of pathology.

[11]  A. Niemierko,et al.  Low-dose neoadjuvant external beam radiation therapy for soft tissue sarcoma. , 2011, International journal of radiation oncology, biology, physics.

[12]  M. Koshy,et al.  Improved survival with radiation therapy in high-grade soft tissue sarcomas of the extremities: a SEER analysis. , 2010, International journal of radiation oncology, biology, physics.

[13]  F. Collin,et al.  Soft tissue sarcomas of the trunk wall (STS-TW): a study of 343 patients from the French Sarcoma Group (FSG) database. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  L. Koniaris,et al.  Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry. , 2007, The Journal of surgical research.

[15]  P. F. D. de Bruin,et al.  Risk factors for pulmonary complications after emergency abdominal surgery. , 2007, Respiratory medicine.

[16]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[17]  C. Antonescu,et al.  Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  G. Rosen,et al.  High-Grade Extremity Soft Tissue Sarcomas: Factors Predictive of Local Recurrence and its Effect on Morbidity and Mortality , 2003, Annals of surgery.

[19]  A. Garden,et al.  Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. , 2002, International journal of radiation oncology, biology, physics.

[20]  M. Heslin,et al.  Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  D H Leung,et al.  Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  F. Collin,et al.  Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  A. Santoro,et al.  Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  L. Harrison,et al.  Long-term results of a prospective randomized trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunk. , 1993, International journal of radiation oncology, biology, physics.

[25]  E. Casper,et al.  The role of multimodality therapy in soft-tissue sarcoma. , 1991, Annals of surgery.

[26]  S. Rosenberg,et al.  Patterns of recurrence in patients with high-grade soft-tissue sarcomas. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  S. Rosenberg,et al.  Perspectives on the role of surgery and radiation therapy in the treatment of soft tissue sarcomas of the extremities. , 1981, Seminars in oncology.

[28]  J. Hendry,et al.  Radiobiology for the Radiologist , 1979, British Journal of Cancer.

[29]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[30]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[31]  K. Goodman,et al.  Clinical Investigation : Sarcoma Reduced Toxicity With Intensity Modulated Radiation Therapy ( IMRT ) for Desmoplastic Small Round Cell Tumor ( DSRCT ) : An Update on the Whole Abdominopelvic Radiation Therapy ( WAP-RT ) Experience , 2022 .

[32]  D. Brizel,et al.  National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology , 2012 .

[33]  Monica Morrow,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials , 2007 .

[34]  S. Steinberg,et al.  Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  N. Dubrawsky.  Cancer statistics , 2022 .